These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters. Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995 [TBL] [Abstract][Full Text] [Related]
29. Persistence of fluphenazine in plasma after decanoate withdrawal. Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000 [TBL] [Abstract][Full Text] [Related]
30. PHENOTHIAZINE REDUCTION AS A CAUSE OF REHOSPITALIZATION. GANTZ RS; BIRKETT DP Arch Gen Psychiatry; 1965 Jun; 12():586-8. PubMed ID: 14286887 [No Abstract] [Full Text] [Related]
31. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study. Dudley J; Rauw G; Hawes EM; Keegan DL; Midha KK Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):791-5. PubMed ID: 6686710 [TBL] [Abstract][Full Text] [Related]
32. ALTERATIONS IN RESPONSE TO SOMATIC PAIN ASSOCIATED WITH ANAESTHESIA. XV. FURTHER STUDIES WITH PHENOTHIAZINE DERIVATIVES AND SIMILAR DRUGS. DUNDEE JW; LOVE WJ; MOORE J Br J Anaesth; 1963 Oct; 35():597-610. PubMed ID: 14073476 [No Abstract] [Full Text] [Related]
33. Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients. Van Putten T; Aravagiri M; Marder SR; Wirshing WC; Mintz J; Chabert N Psychopharmacol Bull; 1991; 27(2):91-6. PubMed ID: 1924666 [TBL] [Abstract][Full Text] [Related]
34. STUDIES OF DRUGS GIVEN BEFORE ANAESTHESIA. VI. THE PHENOTHIAZINE DERIVATIVES. DUNDEE JW; MOORE J; LOVE WJ; NICHOLL RM; CLARKE RS Br J Anaesth; 1965 May; 37():332-53. PubMed ID: 14314889 [No Abstract] [Full Text] [Related]
35. Sensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with coulometric detection. Luo JP; Hubbard JW; Midha KK J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):303-8. PubMed ID: 9061468 [TBL] [Abstract][Full Text] [Related]
36. Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat. Aravagiri M; Marder SR; Yuwiler A; Midha KK; Kula NS; Baldessarini RJ Neuropsychopharmacology; 1995 Nov; 13(3):235-47. PubMed ID: 8602896 [TBL] [Abstract][Full Text] [Related]
37. Fluphenazine decanoate. Its steady-state pharmacologic profile and relationship to tardive dyskinesia. Glazer WM Schizophr Res; 1988; 1(6):425-9. PubMed ID: 3154530 [TBL] [Abstract][Full Text] [Related]
38. Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration. Costello S; Heffron B; Taddei L; Benoit M; Hurt L; Simpson L; Bishop J; Folker-Calderon D; Negrusz A J Anal Toxicol; 2013 Oct; 37(8):594-9. PubMed ID: 23986099 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the effect of the R2 phenothiazine ring substituent on fluphenazine and perphenazine interactions with cyclodextrins. Lutka A; Prange W Acta Pol Pharm; 2005; 62(6):419-25. PubMed ID: 16583980 [TBL] [Abstract][Full Text] [Related]